Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Greenidge Generation Holdings Inc (Class A) | George Rogers | Director | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 09 Sep 2026 | 2,923,976 | 3,039,467 | - | 1.7 | 4,999,999 | Class A Common Stock |
| Safe Pro Grp Inc | Daniyel Erdberg | Director, Chairman and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 09 Sep 2026 | 1,000,000 | 3,749,058 | - | 4 | 4,000,000 | Common Stock |
| Cadiz Inc | Jacinto J. Hernandez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 800,000 | 800,000 | - | - | Performance Rights | |
| Cadiz Inc | Jacinto J. Hernandez | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 800,000 | 800,000 (2%) | 2% | 0 | Common Stock | |
| Barinthus Biotherapeutics PLC. (ADR) | William J. Enright | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 728,454 | 0 | - | - | Ordinary Shares | |
| Barinthus Biotherapeutics PLC. (ADR) | William J. Enright | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 600,000 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | William J. Enright | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 514,923 | 0 | - | - | Ordinary Shares | |
| Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.12 per share. | 09 Sep 2026 | 468,727 | 4,487,197 (8%) | 0% | 1.1 | 524,974 | Common Stock |
| Barinthus Biotherapeutics PLC. (ADR) | William J. Enright | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 443,981 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | William J. Enright | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 440,000 | 0 | - | - | Share Option (Right to Buy) | |
| Opus Genetics Inc | George Magrath | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.15 per share. | 09 Sep 2026 | 392,157 | 2,124,026 | - | 1.2 | 450,981 | Common Stock |
| Opus Genetics Inc | George Magrath | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 392,157 | 0 | - | - | Warrant (right to buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 361,530 | 361,530 | - | - | Ordinary Shares | |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 361,530 | 0 | - | - | Ordinary Shares | |
| Barinthus Biotherapeutics PLC. (ADR) | William J. Enright | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 359,605 | 0 | - | - | Share Option (Right to Buy) | |
| Angel Studios Inc Ordinary | Steven I. Sarowitz | Director | Purchase of securities on an exchange or from another person at price $ 5.28 per share. | 09 Sep 2026 | 355,998 | 1,240,841 | - | 5.3 | 1,879,349 | Class A Common Stock, par value $0.0001 per share |
| Warner Bros. (Class A) | Amy Girdwood | Chief People & Culture Officer | Sale of securities on an exchange or to another person at price $ 27.98 per share. | 09 Sep 2026 | 262,285 | 539,374 (0%) | 0% | 28.0 | 7,338,734 | Series A Common Stock |
| Telos Corp | Gary Mark Bendza | EVP, CFO | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 09 Sep 2026 | 200,000 | 537,008 | - | 4.6 | 910,000 | Common Stock |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 195,166 | 0 | - | - | Share Option (Right to Buy) | |
| TransCode Therapeutics Inc | Thomas A. Fitzgerald | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 185,000 | 185,000 | - | - | Stock Option (right to buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | William J. Enright | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 176,130 | 0 | - | - | Share Option (Right to Buy) | |
| NVIDIA | Nicholas P. Parker | EVP, Worldwide Field Ops | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 172,507 | 172,507 (0%) | 0% | 0 | Common Stock | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.00 per share. | 09 Sep 2026 | 154,912 | 138,351 | - | 42 | 6,506,304 | Common Stock |
| Rigetti Computing Inc | Subodh K. Kulkarni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.96 per share. | 09 Sep 2026 | 150,000 | 260,411 | - | 1.0 | 144,570 | Common Stock |
| Rigetti Computing Inc | Subodh K. Kulkarni | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 150,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Century Therapeutics Inc | Joseph Truitt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 148,000 | 148,000 | - | - | Stock Option (right to buy) | |
| AdaptHealth Corp | Harriss T. Currie | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 141,372 | 141,372 (0%) | 0% | 0 | Common Stock | |
| Barinthus Biotherapeutics PLC. (ADR) | Leon Hooftman | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 140,000 | 0 | - | - | Share Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 135,000 | 135,000 | - | - | Employee Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Diego Miralles | President & Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 135,000 | 135,000 | - | - | Employee Stock Option (Right to Buy) | |
| Angel Studios Inc Ordinary | Steven I. Sarowitz | Director | Purchase of securities on an exchange or from another person at price $ 4.95 per share. | 09 Sep 2026 | 132,639 | 884,843 | - | 5.0 | 657,054 | Class A Common Stock, par value $0.0001 per share |
| Elastic N.V | Shay Banon | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 86.55 per share. | 09 Sep 2026 | 127,892 | 4,022,088 (4%) | 0% | 86.6 | 11,069,053 | Ordinary Shares |
| Relmada Therapeutics Inc | Maged Shenouda | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.20 per share. | 09 Sep 2026 | 120,200 | 920,200 (6%) | 0% | 4.2 | 504,840 | Common Stock |
| Rigetti Computing Inc | Subodh K. Kulkarni | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.68 per share. | 09 Sep 2026 | 120,000 | 140,411 | - | 15.7 | 1,882,104 | Common Stock |
| Artiva Biotherapeutics Inc | Christopher P. Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 120,000 | 120,000 | - | - | Employee Stock Option (Right to Buy) | |
| Arbe Robotics Ltd | Yair Shamir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 120,000 | 120,000 | - | - | Stock Options | |
| Arbe Robotics Ltd | E. Scott Crist | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 120,000 | 120,000 | - | - | Stock Options | |
| Lululemon Athletica | Heidi O'Neill | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 105,295 | 105,295 | - | - | Stock Options (Right to Buy) | |
| Grace Therapeutics Inc | Prashant Kohli | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 09 Sep 2026 | 100,000 | 121,357 (0%) | 0% | 2.1 | 214,000 | Common Stock |
| Scynexis Inc | Sanjay Subramanian | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Relmada Therapeutics Inc | Sergio Traversa | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.18 per share. | 09 Sep 2026 | 100,000 | 1,400,000 (9%) | 0% | 4.2 | 418,000 | Common Stock |
| Relmada Therapeutics Inc | Sergio Traversa | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.10 per share. | 09 Sep 2026 | 100,000 | 1,500,000 (10%) | 0% | 4.1 | 410,000 | Common Stock |
| Eastside Distilling Inc | Nicholas R. Liuzza | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 09 Sep 2026 | 93,200 | 5,006,799 (51%) | 0% | 1.0 | 94,225 | Common Stock |
| Artiva Biotherapeutics Inc | Subhashis Banerjee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 85,000 | 85,000 | - | - | Employee Stock Option (Right to Buy) | |
| Relmada Therapeutics Inc | Maged Shenouda | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.25 per share. | 09 Sep 2026 | 79,800 | 1,000,000 (6%) | 0% | 4.3 | 339,150 | Common Stock |
| Genpact Ltd | Sumita Pandit | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 76,713 | 76,713 (0%) | 0% | 0 | Common Shares | |
| Whitehawk Therapeutics Inc | Vijay K. Iyengar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 76,080 | 76,080 | - | - | Stock Option (right to buy) | |
| Opus Genetics Inc | George Magrath | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.97 per share. | 09 Sep 2026 | 75,541 | 2,048,485 | - | 6.0 | 450,980 | Common Stock |
| Complete Solaria Inc (Class A) | Adam Gishen | Director | Sale of securities on an exchange or to another person at price $ 0.31 per share. | 09 Sep 2026 | 70,000 | 140,655 | - | 0.3 | 21,700 | Common Stock |
| NextDecade Corp | Matthew Schatzman | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.54 per share. | 09 Sep 2026 | 69,583 | 5,319,526 (4%) | 0% | 7.5 | 524,656 | Common Stock |
| Essential Properties Realty Trust Inc | Robert Max Jenkins | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 67,476 | 87,971 | - | - | OP Units | |
| Essential Properties Realty Trust Inc | Robert W. Salisbury | Executive VP, CFO and CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 67,476 | 83,324 | - | - | OP Units | |
| National Energy Services Reunited Corp | Antonio J. Campo Mejia | Director | Sale of securities on an exchange or to another person at price $ 35.45 per share. | 09 Sep 2026 | 63,324 | 696,398 (0%) | 0% | 35.5 | 2,244,836 | Ordinary Shares |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 60,686 | 0 | - | - | Stock Option | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 09 Sep 2026 | 60,686 | 258,437 | - | 18 | 1,092,348 | Common Stock |
| Greenidge Generation Holdings Inc (Class A) | Michael Neuscheler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 60,000 | 97,113 | - | 0 | Class A Common Stock | |
| Greenidge Generation Holdings Inc (Class A) | George Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 60,000 | 77,240 | - | 0 | Class A Common Stock | |
| Greenidge Generation Holdings Inc (Class A) | Michael Neuscheler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 60,000 | 63,711 | - | 0 | Class A Common Stock | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 59,400 | 0 | - | - | Stock Option | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.32 per share. | 09 Sep 2026 | 59,400 | 197,751 | - | 19.3 | 1,147,608 | Common Stock |
| Ocugen Inc | Shankar Musunuri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.12 per share. | 09 Sep 2026 | 57,264 | 1,088,035 (2%) | 0% | 1.1 | 64,136 | Common Stock |
| Starbucks | Brian R. Niccol | Director, chairman and ceo | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.04 per share. | 09 Sep 2026 | 56,267 | 428,696 (0%) | 0% | 100.0 | 5,628,951 | Common Stock |
| Dorian LPG Ltd | Tim T. Hansen | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 53.12 per share. | 09 Sep 2026 | 50,000 | 107,675 (0%) | 0% | 53.1 | 2,655,890 | Common Shares, $0.01 par value per share |
| Korsana Biosciences Inc | Nimish Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 48,445 | 48,445 | - | - | Stock Option (Right to Buy) | |
| Korsana Biosciences Inc | Andrew Gottesdiener | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 48,445 | 48,445 | - | - | Stock Option (Right to Buy) | |
| Korsana Biosciences Inc | Michelle Patricia Pernice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 48,445 | 48,445 | - | - | Stock Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 48,256 | 0 | - | - | Ordinary Shares | |
| Innventure Inc | Gregory William Haskell | Former Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 09 Sep 2026 | 46,460 | 933,343 | - | 0 | Common Stock | |
| Invesco Ltd | Stephanie C. Butcher | Senior Managing Director | Sale of securities on an exchange or to another person at price $ 32.28 per share. | 09 Sep 2026 | 45,095 | 10,205 (0%) | 0% | 32.3 | 1,455,779 | Common Shares |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 45,000 | 374,529 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Diego Miralles | President & Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 45,000 | 122,500 | - | 0 | Common Stock | |
| Chime Fin Inc (Class A) | Ryan King | Director, Co-Founder | Sale of securities on an exchange or to another person at price $ 35.15 per share. | 09 Sep 2026 | 42,421 | 0 | - | 35.1 | 1,490,996 | Class A Common Stock |
| Greenidge Generation Holdings Inc (Class A) | Michael Neuscheler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 42,349 | 139,462 | - | 0 | Class A Common Stock | |
| Greenidge Generation Holdings Inc (Class A) | Michael Neuscheler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 42,349 | 106,060 | - | 0 | Class A Common Stock | |
| Lululemon Athletica | Heidi O'Neill | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 40,223 | 40,223 | - | - | Stock Options (Right to Buy) | |
| Artiva Biotherapeutics Inc | Christopher P. Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 40,000 | 323,084 | - | 0 | Common Stock | |
| Greenidge Generation Holdings Inc (Class A) | George Rogers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 38,251 | 115,491 | - | 0 | Class A Common Stock | |
| Beta Bionics Inc | Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.46 per share. | 09 Sep 2026 | 36,870 | 87,157 | - | 18.5 | 680,723 | Common Stock |
| Beta Bionics Inc | Mark Hopman | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.46 per share. | 09 Sep 2026 | 35,994 | 88,033 | - | 18.5 | 664,550 | Common Stock |
| Chime Fin Inc (Class A) | Ryan King | Director, Co-Founder | 09 Sep 2026 | 34,941 | 42,421 | - | 0 | Class A Common Stock | ||
| Chime Fin Inc (Class A) | Ryan King | Director, Co-Founder | 09 Sep 2026 | 34,941 | 11,810,900 | - | - | Class B Common Stock | ||
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 34,826 | 13,075 | - | - | Stock Option | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.27 per share. | 09 Sep 2026 | 34,826 | 293,263 | - | 17.3 | 601,445 | Common Stock |
| Barinthus Biotherapeutics PLC. (ADR) | Karen A. Dawes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 34,328 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Anne M. Phillips | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 34,328 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 34,328 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Alex Hammacher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 34,328 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Pierre A. Morgon | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 34,328 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Joseph C.F. Scheeren | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 34,328 | 0 | - | - | Share Option (Right to Buy) | |
| Eastside Distilling Inc | Nicholas R. Liuzza | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 09 Sep 2026 | 33,190 | 5,039,989 (52%) | 0% | 1.0 | 34,650 | Common Stock |
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 64.31 per share. | 09 Sep 2026 | 31,428 | 330,098 (1%) | 0% | 64.3 | 2,021,125 | Class A Common Stock |
| Lucky Strike Entertainment Corp (Class A) | Thomas F. Shannon | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.86 per share. | 09 Sep 2026 | 30,000 | 3,144,000 | - | 5.9 | 175,800 | Class A Common Stock |
| Lam Research | Timothy M. Archer | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 30,000 | 31,400 | - | - | Employee Stock Option (Right to Buy) | |
| Lam Research | Timothy M. Archer | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.03 per share. | 09 Sep 2026 | 30,000 | 1,105,966 (0%) | 0% | 30.0 | 900,990 | Common Stock |
| Lam Research | Timothy M. Archer | President and CEO | Sale of securities on an exchange or to another person at price $ 319.26 per share. | 09 Sep 2026 | 30,000 | 1,075,966 (0%) | 0% | 319.3 | 9,577,800 | Common Stock |
| WisdomTree Inc | R. Jarrett | President and COO | Sale of securities on an exchange or to another person at price $ 24.56 per share. | 09 Sep 2026 | 30,000 | 1,080,245 (0%) | 0% | 24.6 | 736,800 | Common Stock |
| Inno Holdings Inc | Ding Wei | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 30,000 | 30,313 | - | 0 | Common Stock, with no par value | |
| Artiva Biotherapeutics Inc | Subhashis Banerjee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 30,000 | 170,947 | - | 0 | Common Stock | |
| Elastic N.V | Ashutosh Kulkarni | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 87.78 per share. | 09 Sep 2026 | 29,227 | 599,525 (0%) | 0% | 87.8 | 2,565,546 | Ordinary Shares |
| Lululemon Athletica | Heidi O'Neill | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 28,079 | 28,079 | - | - | Restricted Stock Units | |
| Insmed Inc | David R. Brennan | Director | Sale of securities on an exchange or to another person at price $ 124.00 per share. | 09 Sep 2026 | 25,000 | 39,238 (0%) | 0% | 124 | 3,100,000 | Common Stock |
| Barinthus Biotherapeutics PLC. (ADR) | Joseph C.F. Scheeren | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 23,000 | 0 | - | - | Ordinary Shares | |
| Eastside Distilling Inc | Nicholas R. Liuzza | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 09 Sep 2026 | 22,500 | 4,913,599 (50%) | 0% | 1.0 | 23,443 | Common Stock |
| Oxford Ind Inc | Thomas C. Chubb | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 09 Sep 2026 | 21,660 | 21,660 (0%) | 0% | 0 | Common Stock | |
| Oxford Ind Inc | Thomas C. Chubb | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 09 Sep 2026 | 21,660 | 30,200 (0%) | 0% | 0 | Common Stock | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,394 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Pierre A. Morgon | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,394 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Karen A. Dawes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,174 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Anne M. Phillips | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,174 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,174 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Alex Hammacher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,174 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Pierre A. Morgon | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,174 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Joseph C.F. Scheeren | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 20,174 | 0 | - | - | Share Option (Right to Buy) | |
| BlackSky Tech Inc (Class A) | Brian E. O'Toole | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 21.83 per share. | 09 Sep 2026 | 20,000 | 1,119,676 | - | 21.8 | 436,600 | Class A Common Stock |
| United States Lime & Minerals Inc | Antoine M. Doumet | Director | Sale of securities on an exchange or to another person at price $ 110.00 per share. | 09 Sep 2026 | 20,000 | 90,000 (1%) | 0% | 110 | 2,200,000 | USLM Common Stock |
| Snap Inc (Class A) | Rebecca Morrow | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.35 per share. | 09 Sep 2026 | 20,000 | 578,105 (0%) | 0% | 5.3 | 106,984 | Class A Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 20,000 | 121,552 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 20,000 | 81,552 | - | - | Option to Purchase Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.41 per share. | 09 Sep 2026 | 20,000 | 787,780 (0%) | 0% | 18.4 | 368,200 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.41 per share. | 09 Sep 2026 | 20,000 | 787,780 (0%) | 0% | 18.4 | 368,200 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.41 per share. | 09 Sep 2026 | 20,000 | 787,780 (0%) | 0% | 18.4 | 368,200 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 20,000 | 101,552 | - | - | Option to Purchase Common Stock | |
| Metagenomi Inc | Laurence E. Reid | Director | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 09 Sep 2026 | 19,883 | 19,883 | - | 1.2 | 23,263 | Common Stock |
| Barinthus Biotherapeutics PLC. (ADR) | Karen A. Dawes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,516 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Anne M. Phillips | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,516 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,516 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Alex Hammacher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,516 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Pierre A. Morgon | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,516 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Joseph C.F. Scheeren | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,516 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Karen A. Dawes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,197 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Anne M. Phillips | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,197 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,197 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Alex Hammacher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,197 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Pierre A. Morgon | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,197 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Joseph C.F. Scheeren | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 19,197 | 0 | - | - | Share Option (Right to Buy) | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.04 per share. | 09 Sep 2026 | 18,729 | 138,351 | - | 42.0 | 787,358 | Common Stock |
| Barinthus Biotherapeutics PLC. (ADR) | Karen A. Dawes | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 18,604 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Anne M. Phillips | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 18,604 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Robin Wright | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 18,604 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Alex Hammacher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 18,604 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Pierre A. Morgon | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 18,604 | 0 | - | - | Share Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Joseph C.F. Scheeren | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 18,604 | 0 | - | - | Share Option (Right to Buy) | |
| Meta | Christopher K. Cox | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 650.21 per share. | 09 Sep 2026 | 18,578 | 245,938 (0%) | 0% | 650.2 | 12,079,640 | Class A Common Stock |
| Cava Grp Inc | Theodore Xenohristos | Director, Chief Concept Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 16,500 | 16,500 | - | 0 | Common Stock | |
| Cava Grp Inc | Theodore Xenohristos | Director, Chief Concept Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 16,500 | 308,130 | - | 0 | Common Stock | |
| Greenidge Generation Holdings Inc (Class A) | George Rogers | Director | 09 Sep 2026 | 16,000 | 3,055,467 | - | 0 | Class A Common Stock | ||
| Greenidge Generation Holdings Inc (Class A) | George Rogers | Director | 09 Sep 2026 | 16,000 | 0 | - | - | Class B Common Stock | ||
| Five Point Holdings LLC (Class A) | Gary H. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 15,779 | 15,779 (0%) | 0% | 0 | Class A common shares | |
| Five Point Holdings LLC (Class A) | Michael E. Rossi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 15,779 | 15,779 (0%) | 0% | 0 | Class A common shares | |
| Five Point Holdings LLC (Class A) | Kathleen Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 15,779 | 151,483 (0%) | 0% | 0 | Class A common shares | |
| Five Point Holdings LLC (Class A) | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 15,779 | 151,458 (0%) | 0% | 0 | Class A common shares | |
| Five Point Holdings LLC (Class A) | William L. Browning | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 15,779 | 133,684 (0%) | 0% | 0 | Class A common shares | |
| Five Point Holdings LLC (Class A) | Michael H. Winer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 15,779 | 168,662 (0%) | 0% | 0 | Class A common shares | |
| ElectroCore Inc | Thomas J. Errico | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 15,572 | 358,904 (1%) | 0% | 0 | Common Stock | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 107.15 per share. | 09 Sep 2026 | 15,492 | 772,288 (0%) | 0% | 107.2 | 1,660,030 | Common Stock |
| NextDecade Corp | Vera de Gyarfas | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.54 per share. | 09 Sep 2026 | 15,463 | 955,103 (0%) | 0% | 7.5 | 116,591 | Common Stock |
| Lantronix Inc | Saleel Awsare | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 5.18 per share. | 09 Sep 2026 | 15,000 | 453,381 (1%) | 0% | 5.2 | 77,685 | Common stock |
| Elastic N.V | Shay Banon | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 88.08 per share. | 09 Sep 2026 | 14,991 | 4,007,097 (4%) | 0% | 88.1 | 1,320,407 | Ordinary Shares |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 107.01 per share. | 09 Sep 2026 | 14,588 | 773,192 (0%) | 0% | 107.0 | 1,561,091 | Common Stock |
| Microsoft | Bradford L. Smith | Vice Chair and President | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 14,000 | 444,716 (0%) | 0% | 0 | Common Stock | |
| 10x Genomics Inc (Class A) | Adam S. Taich | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 65.26 per share. | 09 Sep 2026 | 13,754 | 316,344 (1%) | 0% | 65.3 | 897,550 | Class A Common Stock |
| Hillman Soln Corp | Amanda Kitzberger | Chief Leg. Offic. & Secretary | Sale of securities on an exchange or to another person at price $ 7.25 per share. | 09 Sep 2026 | 13,750 | 58,855 | - | 7.3 | 99,688 | Common Stock |
| PHINIA Inc | Chris P. Gropp | Senior Vice President and CFO | Sale of securities on an exchange or to another person at price $ 66.71 per share. | 09 Sep 2026 | 13,500 | 43,823 | - | 66.7 | 900,536 | Common Stock |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 107.22 per share. | 09 Sep 2026 | 13,304 | 774,476 (0%) | 0% | 107.2 | 1,426,481 | Common Stock |
| Stoneridge Inc | Natalia Noblet | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 12,264 | 49,599 | - | - | Share Units | |
| Stoneridge Inc | Natalia Noblet | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 12,264 | 17,264 (0%) | 0% | 0 | Common Shares, without par value | |
| SiTime Corp | Rajesh Vashist | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 603.47 per share. | 09 Sep 2026 | 12,000 | 345,544 (2%) | 0% | 603.5 | 7,241,640 | Common Stock |
| Health In Tech Inc (Class A) | Timothy Hayes | Director | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 09 Sep 2026 | 12,000 | 120,780 | - | 0.9 | 10,920 | Class A Common Stock |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.60 per share. | 09 Sep 2026 | 11,923 | 103,770 (0%) | 0% | 126.6 | 1,509,452 | Common Stock |
| Oxford Ind Inc | Thomas C. Chubb | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 09 Sep 2026 | 11,785 | 51,860 (0%) | 0% | 0 | Common Stock | |
| Oxford Ind Inc | Thomas C. Chubb | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 09 Sep 2026 | 11,785 | 0 (0%) | 0% | 0 | Common Stock | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 11,697 | 0 | - | - | Employee Stock Option (right to buy) | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.68 per share. | 09 Sep 2026 | 11,697 | 115,693 (0%) | 0% | 61.7 | 721,471 | Common Stock |
| ElectroCore Inc | John P. Gandolfo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 11,123 | 99,221 (0%) | 0% | 0 | Common Stock | |
| ElectroCore Inc | Patricia Wilber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 11,123 | 83,448 (0%) | 0% | 0 | Common Stock | |
| ElectroCore Inc | Julie Ann Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 11,123 | 112,510 (0%) | 0% | 0 | Common Stock | |
| ElectroCore Inc | James Charles Theofilos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 11,123 | 34,670 (0%) | 0% | 0 | Common Stock | |
| ElectroCore Inc | Elena Bonfiglioli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 11,123 | 41,672 (0%) | 0% | 0 | Common Stock | |
| Appian Corp (Class A) | Barbara Kilberg | Director | 09 Sep 2026 | 10,800 | 10,800 (0%) | 0% | - | Class A Common Stock | ||
| Appian Corp (Class A) | Barbara Kilberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 10,800 | 10,800 | - | - | Class B Common Stock | |
| Appian Corp (Class A) | Barbara Kilberg | Director | 09 Sep 2026 | 10,800 | 0 | - | - | Class B Common Stock | ||
| Appian Corp (Class A) | Barbara Kilberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 10,800 | 0 | - | - | Stock Option (Right to Buy) | |
| Barinthus Biotherapeutics PLC. (ADR) | Pierre A. Morgon | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 10,506 | 0 | - | - | Ordinary Shares | |
| Gamestop Corp (Class A) | James Grube | Director | Purchase of securities on an exchange or from another person at price $ 19.12 per share. | 09 Sep 2026 | 10,255 | 39,694 (0%) | 0% | 19.1 | 196,076 | Class A Common Stock |
| Ellington Fin Inc | Lisa Mumford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,181 | 98,954 (0%) | 0% | 0 | Common Stock | |
| Ellington Fin Inc | Ronald I. Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,181 | 90,181 (0%) | 0% | 0 | Common Stock | |
| Ellington Fin Inc | Edward Resendez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,181 | 76,548 | - | - | OP LTIP Units | |
| Ellington Fin Inc | Stephen J. Dannhauser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,181 | 45,679 | - | - | OP LTIP Units | |
| Audiocodes | Stanley B. Stern | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,000 | 80,000 (0%) | 0% | 0 | Ordinary Shares | |
| Audiocodes | Doron Nevo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,000 | 60,000 (0%) | 0% | 0 | Ordinary Shares | |
| Audiocodes | Yosef Tena | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,000 | 94,500 (0%) | 0% | 0 | Ordinary Shares | |
| Audiocodes | Zehava Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,000 | 80,000 (0%) | 0% | 0 | Ordinary Shares | |
| Audiocodes | Shira Fayans Birenbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,000 | 46,250 (0%) | 0% | 0 | Ordinary Shares | |
| Audiocodes | Itay Makov | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 10,000 | 20,000 (0%) | 0% | 0 | Ordinary Shares | |
| Live Oak Bancshares Inc | James S. Mahan | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.63 per share. | 09 Sep 2026 | 10,000 | 2,757,844 (7%) | 0% | 38.6 | 386,312 | Voting Common Stock |
| Live Oak Bancshares Inc | James S. Mahan | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.75 per share. | 09 Sep 2026 | 10,000 | 2,747,844 (7%) | 0% | 38.7 | 387,485 | Voting Common Stock |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Sale of securities on an exchange or to another person at price $ 67.34 per share. | 09 Sep 2026 | 10,000 | 1,316,594 (2%) | 0% | 67.3 | 673,400 | Common Stock |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 97.54 per share. | 09 Sep 2026 | 10,000 | 11,000 | - | 97.5 | 975,400 | Class A Common Stock |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 09 Sep 2026 | 10,000 | 21,000 | - | 2.8 | 28,000 | Class A Common Stock |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.80 per share. | 09 Sep 2026 | 10,000 | 11,000 | - | 2.8 | 28,000 | Class A Common Stock |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 10,000 | 560,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 10,000 | 570,000 | - | - | Stock Option (right to buy) | |
| Billiontoone Inc Ordinary | David Tsao | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 09 Sep 2026 | 10,000 | 1,000 | - | 100 | 1,000,000 | Class A Common Stock |
| Oxford Ind Inc | Thomas C. Chubb | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 09 Sep 2026 | 9,875 | 40,075 (0%) | 0% | 0 | Common Stock | |
| Oxford Ind Inc | Thomas C. Chubb | Director, CEO and President | Other type of transaction at price $ 0.00 per share. | 09 Sep 2026 | 9,875 | 11,785 (0%) | 0% | 0 | Common Stock | |
| J.Jill Inc | Mark W. Webb | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 21.42 per share. | 09 Sep 2026 | 9,867 | 150,682 (0%) | 0% | 21.4 | 211,351 | Common Stock |
| Elastic N.V | Mark Eugene Dodds | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 87.78 per share. | 09 Sep 2026 | 9,673 | 288,538 (0%) | 0% | 87.8 | 849,096 | Ordinary Shares |
| Lam Research | Bethany J. Mayer | Director | Sale of securities on an exchange or to another person at price $ 314.74 per share. | 09 Sep 2026 | 9,557 | 20,995 (0%) | 0% | 314.7 | 3,007,970 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 9,500 | 470,910 | - | - | Stock Option | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 117.76 per share. | 09 Sep 2026 | 9,500 | 333,943 (0%) | 0% | 117.8 | 1,118,720 | Common Stock |
| Safehold Inc | Robin Josephs | Director | Sale of securities on an exchange or to another person at price $ 14.56 per share. | 09 Sep 2026 | 9,500 | 89,068 (0%) | 0% | 14.6 | 138,348 | Common Stock |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Sale of securities on an exchange or to another person at price $ 67.79 per share. | 09 Sep 2026 | 9,428 | 1,327,166 (2%) | 0% | 67.8 | 639,124 | Common Stock |
| Gen Digital | Eric K. Brandt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 9,072 | 17,894 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Nora M. Denzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 9,072 | 52,754 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | John C. Chrystal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 9,072 | 40,491 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Susan P. Barsamian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 9,072 | 17,894 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Ondrej Vlcek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 9,072 | 3,341,848 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Pavel Baudis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 9,072 | 42,637 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Sherrese M. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 9,072 | 82,954 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Emily Heath | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 9,072 | 76,274 (0%) | 0% | 0 | Common Stock | |
| Peloton Interactive Inc | Angel L. Mendez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 9,022 | 9,023 | - | - | Restricted Stock Unit (RSU) | |
| Peloton Interactive Inc | Angel L. Mendez | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 9,022 | 142,634 (0%) | 0% | - | Class A Common Stock | |
| Peloton Interactive Inc | Karen Boone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 9,022 | 9,023 | - | - | Restricted Stock Unit (RSU) | |
| Peloton Interactive Inc | Karen Boone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 9,022 | 245,085 (0%) | 0% | - | Class A Common Stock | |
| Elastic N.V | Navam Welihinda | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.78 per share. | 09 Sep 2026 | 8,961 | 200,293 (0%) | 0% | 87.8 | 786,597 | Ordinary Shares |
| Gen Digital | Eric K. Brandt | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 8,822 | 78,506 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Eric K. Brandt | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 8,822 | 9,072 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Susan P. Barsamian | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 8,822 | 99,885 (0%) | 0% | 0 | Common Stock | |
| Gen Digital | Susan P. Barsamian | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 8,822 | 9,072 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.22 per share. | 09 Sep 2026 | 8,750 | 235,689 (0%) | 0% | 5.2 | 45,675 | Common Stock |
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.65 per share. | 09 Sep 2026 | 8,750 | 244,439 (0%) | 0% | 2.7 | 23,188 | Common Stock |
| Aquestive Therapeutics Inc | Sherry Korczynski | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 8,750 | 26,250 | - | - | Non-Qualified Stock Option (right to buy) | |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 22.66 per share. | 09 Sep 2026 | 8,560 | 1,631,185 (2%) | 0% | 22.7 | 193,970 | Class A Common Stock |
| Peloton Interactive Inc | Pamela Thomas-Graham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 8,458 | 143,234 (0%) | 0% | - | Class A Common Stock | |
| Peloton Interactive Inc | Pamela Thomas-Graham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 8,458 | 8,459 | - | - | Restricted Stock Unit (RSU) | |
| Peloton Interactive Inc | Tara Comonte | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 8,458 | 69,583 (0%) | 0% | - | Class A Common Stock | |
| Peloton Interactive Inc | Tara Comonte | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 8,458 | 8,459 | - | - | Restricted Stock Unit (RSU) | |
| Donegal Grp Inc (Class A) | David Benjamin Bawel | SVP & CHIEF ACCOUNTING OFFICER | Sale of securities on an exchange or to another person at price $ 19.28 per share. | 09 Sep 2026 | 8,326 | 22,331 (0%) | 0% | 19.3 | 160,509 | Class A Common Stock |
| Donegal Grp Inc (Class A) | David Benjamin Bawel | SVP & CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 8,326 | 0 | - | - | Options | |
| Donegal Grp Inc (Class A) | David Benjamin Bawel | SVP & CHIEF ACCOUNTING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.39 per share. | 09 Sep 2026 | 8,326 | 30,657 (0%) | 0% | 14.4 | 119,811 | Class A Common Stock |
| Sirius XM Holdings Inc | Eddy W. Hartenstein | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 8,193 | 37,117 (0%) | 0% | 0 | Common Stock | |
| Sirius XM Holdings Inc | Eddy W. Hartenstein | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 8,193 | 6,835 (0%) | 0% | 0 | Common Stock | |
| Anterix Inc | Heather Martin | Chief Marketing Officer, Chief of Staff | Sale of securities on an exchange or to another person at price $ 84.20 per share. | 09 Sep 2026 | 8,064 | 26,743 (0%) | 0% | 84.2 | 678,998 | Common Stock |
| NextDecade Corp | Tarik Skeik | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.54 per share. | 09 Sep 2026 | 7,732 | 355,542 (0%) | 0% | 7.5 | 58,299 | Common Stock |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,729 | 60,686 | - | - | Stock Option | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 09 Sep 2026 | 7,729 | 152,680 | - | 18 | 139,122 | Common Stock |
| Perrigo Co PLC | David Ball | EVP & CBDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.34 per share. | 09 Sep 2026 | 7,701 | 14,448 (0%) | 0% | 14.3 | 110,432 | Ordinary Shares |
| Perrigo Co PLC | David Ball | EVP & CBDO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,701 | 0 | - | - | Restricted Stock Units | |
| Kestra Medical Tech Ltd | Raymond Wayne Cohen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,217 | 58,120 | - | - | Common Shares | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,031 | 155,434 (0%) | 0% | 0 | Class A Common Stock | |
| Runway Growth Finance Corp | Michael Rovner | Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.57 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | 6.6 | 45,990 | Common Stock, par value $0.01 per share |
| Netscout Systems Inc | Joseph G. Hadzima | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Joseph G. Hadzima | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 125,185 (0%) | 0% | - | Common Stock | |
| Netscout Systems Inc | Joseph G. Hadzima | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 14,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | John R. Egan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 112,740 (0%) | 0% | - | Common Stock | |
| Netscout Systems Inc | John R. Egan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | John R. Egan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 14,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Vivian Vitale | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Vivian Vitale | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 52,970 (0%) | 0% | - | Common Stock | |
| Netscout Systems Inc | Vivian Vitale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 14,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Robert E. Donahue | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 73,977 (0%) | 0% | - | Common Stock | |
| Netscout Systems Inc | Robert E. Donahue | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Robert E. Donahue | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 14,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Christopher Perretta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 47,866 (0%) | 0% | - | Common Stock | |
| Netscout Systems Inc | Christopher Perretta | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Christopher Perretta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 14,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Alfred Grasso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 14,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Alfred Grasso | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 42,000 (0%) | 0% | - | Common Stock | |
| Netscout Systems Inc | Alfred Grasso | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Shannon K. Nash | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Shannon K. Nash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 14,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Shannon K. Nash | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 25,085 (0%) | 0% | - | Common Stock | |
| Netscout Systems Inc | Marlene Pelage | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 7,000 | - | - | Restricted Stock Unit | |
| Netscout Systems Inc | Marlene Pelage | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 25,085 (0%) | 0% | - | Common Stock | |
| Netscout Systems Inc | Marlene Pelage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 7,000 | 14,000 | - | - | Restricted Stock Unit | |
| Tapestry | Denise Kulikowsky | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.58 per share. | 09 Sep 2026 | 6,910 | 26,946 (0%) | 0% | 40.6 | 280,408 | Common Stock |
| Tapestry | Denise Kulikowsky | Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 6,910 | 13,820 | - | - | Stock Option | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.32 per share. | 09 Sep 2026 | 6,600 | 144,951 | - | 19.3 | 127,512 | Common Stock |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 6,600 | 59,400 | - | - | Stock Option | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 107.82 per share. | 09 Sep 2026 | 6,596 | 767,880 (0%) | 0% | 107.8 | 711,187 | Common Stock |
| Elastic N.V | Shay Banon | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 87.78 per share. | 09 Sep 2026 | 6,577 | 4,149,980 (5%) | 0% | 87.8 | 577,329 | Ordinary Shares |
| Heritage Insurance Holdings Inc | Sharon Binnun | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 33.81 per share. | 09 Sep 2026 | 6,565 | 80,623 (0%) | 0% | 33.8 | 221,995 | Common Stock |
| GeneDx Holdings Corp (Class A) | Katherine A. Stueland | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 6,547 | 110,919 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Katherine A. Stueland | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 6,547 | 6,547 | - | - | Restricted Stock Unit | |
| Bristol-Myers Squibb | Cristian Massacesi | EVP,Chief Med Offr,Head of Dev | Sale of securities on an exchange or to another person at price $ 64.57 per share. | 09 Sep 2026 | 6,249 | 18,748 (0%) | 0% | 64.6 | 403,498 | Common Stock, $0.10 par value |
| Elastic N.V | Shay Banon | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 88.28 per share. | 09 Sep 2026 | 6,126 | 4,000,971 (4%) | 0% | 88.3 | 540,803 | Ordinary Shares |
| Elastic N.V | Shay Banon | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 85.16 per share. | 09 Sep 2026 | 6,101 | 3,994,870 (4%) | 0% | 85.2 | 519,561 | Ordinary Shares |
| Health In Tech Inc (Class A) | Timothy Hayes | Director | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 09 Sep 2026 | 5,730 | 132,780 | - | 0.9 | 5,329 | Class A Common Stock |
| Talos Energy Inc | John B. Spath | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.51 per share. | 09 Sep 2026 | 5,552 | 173,236 (0%) | 0% | 17.5 | 97,216 | Common Stock |
| Elastic N.V | Carolyn Herzog | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 87.78 per share. | 09 Sep 2026 | 5,485 | 112,954 (0%) | 0% | 87.8 | 481,473 | Ordinary Shares |
| Acco Brands Corp | Kathleen S. Dvorak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 5,464 | 320,187 | - | - | Restricted Stock Units | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 107.58 per share. | 09 Sep 2026 | 5,412 | 767,780 (0%) | 0% | 107.6 | 582,228 | Common Stock |
| Yext Inc | Daniel J. Englander | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 5,284 | 5,284 | - | - | Restricted Stock Unit | |
| Standard Motor Products Inc | Carmine J. Broccole | CLO & Secretary | Sale of securities on an exchange or to another person at price $ 39.24 per share. | 09 Sep 2026 | 5,250 | 74,537 (0%) | 0% | 39.2 | 206,010 | Common Stock |
| Lovesac Co | Alan Boehme | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 5,238 | 5,238 (0%) | 0% | 0 | Common Stock, par value $0.00001 | |
| Lovesac Co | Alan Boehme | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 5,238 | 0 | - | - | Restricted Stock Units | |
| Talos Energy Inc | William S. Moss | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.51 per share. | 09 Sep 2026 | 5,208 | 299,909 (0%) | 0% | 17.5 | 91,192 | Common Stock |
| Acco Brands Corp | Edward Mark Rajkowski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 5,127 | 300,451 | - | - | Restricted Stock Units | |
| Stabilis Soln Inc - Registered Shares | Edward L. Kuntz | Director | Purchase of securities on an exchange or from another person at price $ 5.41 per share. | 09 Sep 2026 | 5,000 | 74,839 (0%) | 0% | 5.4 | 27,050 | Common Stock |
| Hippo Holdings Inc | Rick Mccathron | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 32.23 per share. | 09 Sep 2026 | 5,000 | 567,132 | - | 32.2 | 161,150 | Common Stock |
| Acco Brands Corp | Pradeep Jotwani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 4,961 | 290,736 | - | - | Restricted Stock Units | |
| Leslies Inc | Jason B. McDonell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,957 | 56,362 | - | - | Restricted Stock Units | |
| Leslies Inc | Jason B. McDonell | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,957 | 9,536 | - | 0 | Common Stock, par value $0.001 per share | |
| Jakks Pacific Inc | Alexander Shoghi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.44 per share. | 09 Sep 2026 | 4,827 | 17,391 (0%) | 0% | 24.4 | 117,972 | Common Stock |
| Jakks Pacific Inc | Alexander Shoghi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,827 | 0 | - | - | Restricted Stock Unit ("RSU") | |
| Jakks Pacific Inc | Lori MacPherson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.44 per share. | 09 Sep 2026 | 4,827 | 4,827 (0%) | 0% | 24.4 | 117,972 | Common Stock |
| Jakks Pacific Inc | Lori MacPherson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,827 | 0 | - | - | Restricted Stock Unit ("RSU") | |
| Jakks Pacific Inc | Neilwantie Somai-Mahabir | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,827 | 0 | - | - | Restricted Stock Unit ("RSU") | |
| Jakks Pacific Inc | Neilwantie Somai-Mahabir | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.44 per share. | 09 Sep 2026 | 4,827 | 4,827 (0%) | 0% | 24.4 | 117,972 | Common Stock |
| Jakks Pacific Inc | Jonathan Roy Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.44 per share. | 09 Sep 2026 | 4,827 | 4,827 (0%) | 0% | 24.4 | 117,972 | Common Stock |
| Jakks Pacific Inc | Jonathan Roy Liebman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,827 | 0 | - | - | Restricted Stock Unit ("RSU") | |
| Pro-Dex Inc (co) | Richard L. Van Kirk | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.45 per share. | 09 Sep 2026 | 4,768 | 79,993 (2%) | 0% | 59.5 | 283,458 | Common Stock |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,749 | 0 | - | - | Employee Stock Option (right to buy) | |
| Dorman Products Inc | Kevin M. Olsen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 82.03 per share. | 09 Sep 2026 | 4,749 | 103,996 (0%) | 0% | 82.0 | 389,560 | Common Stock |
| Tapestry | Denise Kulikowsky | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.40 per share. | 09 Sep 2026 | 4,719 | 16,417 (0%) | 0% | 115.4 | 544,573 | Common Stock |
| Estee Lauder (Class A) | Charlene Barshefsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,697 | 0 | - | - | Stock Option (Right to Buy) | |
| Estee Lauder (Class A) | Charlene Barshefsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.36 per share. | 09 Sep 2026 | 4,697 | 54,745 (0%) | 0% | 78.4 | 368,057 | Class A Common Stock |
| Acco Brands Corp | Robert J. Keller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 4,514 | 264,536 | - | - | Restricted Stock Units | |
| Halozyme Therapeutics Inc | Helen I. Torley | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 107.55 per share. | 09 Sep 2026 | 4,508 | 767,780 (0%) | 0% | 107.5 | 484,826 | Common Stock |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,400 | 47,901 | - | - | Stock Option | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.27 per share. | 09 Sep 2026 | 4,400 | 157,080 | - | 17.3 | 75,988 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 207.83 per share. | 09 Sep 2026 | 4,400 | 7,791,619 (19%) | 0% | 207.8 | 914,452 | Class A common stock |
| Wheels Up Experience Inc (Class A) | Matthew J. Knopf | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.04 per share. | 09 Sep 2026 | 4,345 | 91,521 | - | 4.0 | 17,554 | Class A Common Stock, par value $0.0001 per share |
| Talos Energy Inc | Gregory M. Babcock | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.51 per share. | 09 Sep 2026 | 4,293 | 80,216 (0%) | 0% | 17.5 | 75,170 | Common Stock |
| Pro-Dex Inc (co) | Richard L. Van Kirk | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.72 per share. | 09 Sep 2026 | 4,274 | 90,103 (2%) | 0% | 60.7 | 259,517 | Common Stock |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 4,224 | 0 | - | - | Restricted Stock Units | |
| Acco Brands Corp | Graciela I. Monteagudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 4,149 | 243,174 | - | - | Restricted Stock Units | |
| Bridgewater Bancshares Inc | Douglas J. Parish | Director | Sale of securities on an exchange or to another person at price $ 21.38 per share. | 09 Sep 2026 | 4,000 | 4,107 (0%) | 0% | 21.4 | 85,536 | Common Stock |
| Unum Grp | Lisa G. Iglesias | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 94.44 per share. | 09 Sep 2026 | 4,000 | 25,453 (0%) | 0% | 94.4 | 377,747 | Common Stock |
| J.Jill Inc | Mark W. Webb | EVP, CFO & COO | Sale of securities on an exchange or to another person at price $ 22.10 per share. | 09 Sep 2026 | 3,889 | 146,793 (0%) | 0% | 22.1 | 85,947 | Common Stock |
| Estee Lauder (Class A) | Charlene Barshefsky | Director | Sale of securities on an exchange or to another person at price $ 98.82 per share. | 09 Sep 2026 | 3,775 | 50,970 (0%) | 0% | 98.8 | 373,046 | Class A Common Stock |
| Solidion Tech Inc | Jaymes Winters | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 09 Sep 2026 | 3,725 | 3,725 | - | 0 | Common Stock | |
| Leonardo DRS Inc | Kenneth J. Krieg | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 3,700 | 27,576 | - | 0 | Common Stock | |
| GeneDx Holdings Corp (Class A) | Katherine A. Stueland | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 84.22 per share. | 09 Sep 2026 | 3,692 | 107,227 | - | 84.2 | 310,932 | Class A Common Stock |
| Nike | Venkatesh Alagirisamy | EVP: CHIEF OPERATING OFFICER | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 09 Sep 2026 | 3,671 | 104,861 (0%) | 0% | 37.6 | 137,993 | Class B Common Stock |
| Nike | Robert Leinwand | EVP: Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 09 Sep 2026 | 3,646 | 87,758 (0%) | 0% | 37.6 | 137,053 | Class B Common Stock |
| Tapestry | Denise Kulikowsky | Chief People Officer | Sale of securities on an exchange or to another person at price $ 115.36 per share. | 09 Sep 2026 | 3,619 | 21,136 (0%) | 0% | 115.4 | 417,488 | Common Stock |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.44 per share. | 09 Sep 2026 | 3,579 | 151,855 (0%) | 0% | 96.4 | 345,159 | Class A Common Stock |
| Argan Inc | Charles Collins | CHIEF EXECUTIVE OFFICER, GEMMA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 3,506 | 6,404 | - | - | Time Based Restricted Stock Units | |
| Oxford Ind Inc | Thomas C. Chubb | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 30.93 per share. | 09 Sep 2026 | 3,500 | 33,700 (0%) | 0% | 30.9 | 108,268 | Common Stock |
| Northwest Pipe Co. | Michael C. Franson | Director | Sale of securities on an exchange or to another person at price $ 105.30 per share. | 09 Sep 2026 | 3,500 | 15,924 (0%) | 0% | 105.3 | 368,563 | Common Stock |
| Jakks Pacific Inc | Alexander Shoghi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 3,478 | 3,478 | - | - | Restricted Stock Unit ("RSU") | |
| Jakks Pacific Inc | Lori MacPherson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 3,478 | 3,478 | - | - | Restricted Stock Unit ("RSU") | |
| Jakks Pacific Inc | Neilwantie Somai-Mahabir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 3,478 | 3,478 | - | - | Restricted Stock Unit ("RSU") | |
| Jakks Pacific Inc | Jonathan Roy Liebman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 3,478 | 3,478 | - | - | Restricted Stock Unit ("RSU") | |
| Anterix Inc | Heather Martin | Chief Marketing Officer, Chief of Staff | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.44 per share. | 09 Sep 2026 | 3,465 | 34,807 (0%) | 0% | 85.4 | 296,050 | Common Stock |
| OppFi Inc (Class A) | Todd G. Schwartz | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.59 per share. | 09 Sep 2026 | 3,450 | 633,308 | - | 7.6 | 26,190 | Class A Common Stock |
| Acco Brands Corp | Ronald M. Lombardi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 3,292 | 192,913 | - | - | Restricted Stock Units | |
| Neurocrine Biosciences Inc | Eric S. Benevich | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.24 per share. | 09 Sep 2026 | 3,194 | 66,562 (0%) | 0% | 43.2 | 138,109 | Common Stock |
| Neurocrine Biosciences Inc | Eric S. Benevich | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 3,194 | 0 | - | - | Incentive Stock Option | |
| Barinthus Biotherapeutics PLC. (ADR) | Anne M. Phillips | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 3,000 | 0 | - | - | Ordinary Shares | |
| Barinthus Biotherapeutics PLC. (ADR) | Alex Hammacher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 09 Sep 2026 | 3,000 | 0 | - | - | Ordinary Shares | |
| NPK Intl Inc | Matthew Warren | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 13.41 per share. | 09 Sep 2026 | 2,991 | 51,439 (0%) | 0% | 13.4 | 40,113 | Common Stock |
| Grove Collaborative Holdings Inc (Class A) | Stuart Landesberg | Director | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 09 Sep 2026 | 2,943 | 1,671,851 | - | 1.0 | 3,090 | Class A Common Stock |
| ADP | Vishwas Sugla | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 2,827 | 2,827 (0%) | 0% | 0 | Common Stock | |
| Seagate Tech | William David Mosley | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 2,815 | 297,982 (0%) | 0% | 0 | Ordinary Shares | |
| Seagate Tech | William David Mosley | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 2,815 | 0 | - | - | Restricted Share Unit | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 2,807 | 0 | - | - | Restricted Stock Units | |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 208.61 per share. | 09 Sep 2026 | 2,800 | 7,782,459 (19%) | 0% | 208.6 | 584,108 | Class A common stock |
| Shoals Tech Grp Inc (Class A) | Kirsten Moen | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.06 per share. | 09 Sep 2026 | 2,790 | 95,651 | - | 7.1 | 19,697 | Class A Common Stock |
| Perrigo Co PLC | David Ball | EVP & CBDO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.34 per share. | 09 Sep 2026 | 2,784 | 11,664 (0%) | 0% | 14.3 | 39,923 | Ordinary Shares |
| Macerich Co. | Christopher J. Zecchini | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 23.28 per share. | 09 Sep 2026 | 2,740 | 847 (0%) | 0% | 23.3 | 63,787 | Common Stock |
| Pro-Dex Inc (co) | Richard L. Van Kirk | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.84 per share. | 09 Sep 2026 | 2,691 | 94,377 (2%) | 0% | 59.8 | 161,029 | Common Stock |
| RingCentral Inc (Class A) | Tarun Arora | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 70.74 per share. | 09 Sep 2026 | 2,679 | 65,692 (0%) | 0% | 70.7 | 189,507 | Class A Common Stock |
| Gen Digital | Ondrej Vlcek | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.76 per share. | 09 Sep 2026 | 2,647 | 3,339,201 (0%) | 0% | 29.8 | 78,775 | Common Stock |
| Gen Digital | Pavel Baudis | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.76 per share. | 09 Sep 2026 | 2,647 | 39,990 (0%) | 0% | 29.8 | 78,775 | Common Stock |
| Nike | Philip McCartney | EVP: CHIEF INN,PROD&DSG OFCR | Sale of securities on an exchange or to another person at price $ 37.59 per share. | 09 Sep 2026 | 2,559 | 78,120 (0%) | 0% | 37.6 | 96,193 | Class B Common Stock |
| Getty Images Holdings Inc (Class A) | Jerry Jenkins | SVP, CHRO | Sale of securities on an exchange or to another person at price $ 0.23 per share. | 09 Sep 2026 | 2,558 | 112,316 | - | 0.2 | 588 | Class A Common Stock |
| Acco Brands Corp | Joseph B. Burton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 2,538 | 148,780 | - | - | Restricted Stock Units | |
| Mesa Laboratories Inc | Shiraz S. Ladiwala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 2,510 | 2,510 | - | - | Restricted Stock Units - 7 | |
| Installed Building Products Inc | Jeffrey W. Edwards | Director, President, CEO and Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 2,500 | 193,803 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 2,462 | 2,463 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 2,462 | 42,761 | - | 0 | Class A Common Stock | |
| Mesa Laboratories Inc | Mark Christopher Capone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 2,423 | 2,423 | - | - | Restricted Stock Units - 4 | |
| Seagate Tech | William David Mosley | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 2,415 | 19,328 | - | - | Restricted Share Unit | |
| Seagate Tech | William David Mosley | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 2,415 | 298,864 (0%) | 0% | 0 | Ordinary Shares | |
| Zoom Video Comm Inc (Class A) | Velchamy Sankarlingam | Pres. of Engineering & Product | Sale of securities on an exchange or to another person at price $ 95.76 per share. | 09 Sep 2026 | 2,384 | 149,471 (0%) | 0% | 95.8 | 228,288 | Class A Common Stock |
| Aquestive Therapeutics Inc | Peter Boyd | Chief People Officer | 09 Sep 2026 | 2,293 | 284,024 (0%) | 0% | 1.0 | 2,201 | Common Stock | |
| Aquestive Therapeutics Inc | Peter Boyd | Chief People Officer | 09 Sep 2026 | 2,293 | 0 | - | - | Warrant (Right to Buy) | ||
| Tapestry | Denise Kulikowsky | Chief People Officer | Sale of securities on an exchange or to another person at price $ 115.40 per share. | 09 Sep 2026 | 2,191 | 24,755 (0%) | 0% | 115.4 | 252,841 | Common Stock |
| Pro-Dex Inc (co) | Richard L. Van Kirk | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.92 per share. | 09 Sep 2026 | 2,160 | 97,068 (2%) | 0% | 58.9 | 127,267 | Common Stock |
| Neurocrine Biosciences Inc | Eric S. Benevich | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 154.61 per share. | 09 Sep 2026 | 2,154 | 64,408 (0%) | 0% | 154.6 | 333,030 | Common Stock |
| Pro-Dex Inc (co) | Richard L. Van Kirk | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.85 per share. | 09 Sep 2026 | 2,144 | 85,867 (2%) | 0% | 63.8 | 136,894 | Common Stock |
| PHINIA Inc | Christopher Gustanski | VP, Operational Excellence | Sale of securities on an exchange or to another person at price $ 66.97 per share. | 09 Sep 2026 | 2,097 | 11,301 | - | 67.0 | 140,426 | Common Stock |
| Ouster Inc (Class A) | Megan Chung | General Counsel and Secretary | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 2,084 | 200,775 | - | 0 | Common Stock | |
| ADP | Vishwas Sugla | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 2,073 | 4,900 (0%) | 0% | 0 | Common Stock | |
| Global Self Storage Inc | Mark Campbell Winmill | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 5.16 per share. | 09 Sep 2026 | 2,058 | 372,240 (3%) | 0% | 5.2 | 10,619 | Common Stock |
| Jakks Pacific Inc | Lori MacPherson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.44 per share. | 09 Sep 2026 | 2,042 | 2,785 (0%) | 0% | 24.4 | 49,906 | Common Stock |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 208.86 per share. | 09 Sep 2026 | 2,000 | 7,789,619 (19%) | 0% | 208.9 | 417,720 | Class A common stock |
| Acco Brands Corp | Elizabeth A. Simermeyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 1,940 | 113,693 | - | - | Restricted Stock Units | |
| Crowdstrike (Class A) | George R. Kurtz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 209.71 per share. | 09 Sep 2026 | 1,920 | 7,787,699 (19%) | 0% | 209.7 | 402,643 | Class A common stock |
| Grove Collaborative Holdings Inc (Class A) | Stuart Landesberg | Director | Purchase of securities on an exchange or from another person at price $ 1.05 per share. | 09 Sep 2026 | 1,884 | 1,673,735 | - | 1.0 | 1,978 | Class A Common Stock |
| Visa | Julie B. Rottenberg | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 134.76 per share. | 09 Sep 2026 | 1,867 | 20,271 (0%) | 0% | 134.8 | 251,597 | Class A Common Stock |
| Visa | Julie B. Rottenberg | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2026 | 1,867 | 3,734 | - | - | Employee Stock Option (Right to Buy) | |
| Visa | Julie B. Rottenberg | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 368.34 per share. | 09 Sep 2026 | 1,867 | 18,404 (0%) | 0% | 368.3 | 687,691 | Class A Common Stock |
| CBL& Associates Properties Inc - Ordinary Shares - New | Jeffery V. Curry | Chief Legal Officer & Sec. | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Sep 2026 | 1,800 | 143,018 | - | 0 | Common Stock | |
| Mesa Laboratories Inc | John J. Sullivan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 1,774 | 1,774 | - | - | Restricted Stock Units - 11 | |
| Mesa Laboratories Inc | R. Tony Tripeny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 1,774 | 1,774 | - | - | Restricted Stock Units - 5 | |
| Mesa Laboratories Inc | Shannon M. Hall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 1,774 | 1,774 | - | - | Restricted Stock Units - 9 | |
| Mesa Laboratories Inc | Jennifer S. Alltoft | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2026 | 1,774 | 1,774 | - | - | Restricted Stock Units - 10 |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.